Introduction
Edwardsiella tarda (E. tarda) is an unusual human pathogen that can cause gastroenteritis, soft tissue infection, myonecrosis, bacteremia, cholecystitis, liver abscess, osteomyelitis, and tuboovarian abscess [1] [2] [3] [4] . The most frequent manifestation is gastroenteritis and the least frequent is extra-intestinal infection. Immunocompromised patients are more vulnerable to infection and their mortality rate is reported to be about 50% when associated with bacteremia [1, 5] . This article describes a case of a metastatic gastric cancer patient infected with E. tarda bacteremia who was successfully treated with antimicrobials.
Case presentation
A 78 year old man came to hour hospital complaining of a high grade fever and a shaking chill. He has undergone a pancreatoduodenectomy for a locally advanced gastric cancer two years before, and a liver metastasis was found three months after surgery. His body temperature was 39.1 C and his abdomen was not painful. The patient was diagnosed with retrograde cholangitis on the basis of his recurrent episodes of cholangitis after surgery and having liver function enzymes elevated beyond normal range. We begun antimicrobial therapy with cefmetazole. E. tarda was identified from the blood culture as a causative agent and it was discovered that he had eaten raw seafood two days before his admission day (Chart 1). After 14 days of antimicrobial therapy he was discharged without any complications.
Discussion
E. tarda is a nonfermenting gram-negative bacilli which is identified apart from Salmonella species for producing hydrogen sulfide and indole; and also fermenting only glucose and maltose. It is a member of Eneterobacteriaceae, but rarely colonizes in the human gastrointestinal tract, reported to be found only in 26 of 353,600 Japanese individuals [6] . They are commonly isolated from fresh water environments and habituating animals such as fish and reptiles. Contact with these animals and consumption of contaminated food, e.g., sushi, raw fish, and raw meat, are considered as risk factors of E. tarda infection [4, 5, 7, 8] . Hirai et al. showed that 45.5% of cases of bacteremia have been reported in Japan, where many brackish water areas and rivers are found and much raw seafood is eaten. They also studied the seasonal distribution of all patients infected with E tarda; 77.2% of bacteremia occurred between July and November [5] . Other well established risk factors of the host are hepatobiliary diseases, malignancy, and diabetes mellitus [9] .
Our patient had a clinical history of developing a liver metastasis of the gastric cancer, and an episode of having eaten sushi in July. In addition, he had undergone a pancreatoduodnectoymy and biliary reconstruction which may have allowed the bacteria to more easily enter bloodstream from the intestines.
Once bacteremia has occurred, the mortality ranges from 40 to 50%, [1, 5, 9] regardless of its sensitivity to antimicrobials. In the literature, penicillins, cephalosporins and carbapenems are often utilized. Our patient had a recurrent episode of retrograde cholangitis caused by Escherichia coli with extended spectrum beta lactamase. Based on the evidence that cephamycin is effective against extended spectrum beta lactamase producing Enterobacteriaceae [10] , we begun the antimicrobial treatment with cefmetazole and were successful.
Conclusion
A liver metastatic gastric cancer patient with E. tarda bacteremia was treated successfully with cefmetazole, a second generation cephalosporin. To the best of our knowledge, this is the first case report about E. tarda bacteremia after pancreatoduodenectomy.
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